Is West Pharmaceutical Services, Inc. overvalued?

West Pharmaceutical Services, Inc. (WST) looks overvalued — trading about 51% above its fair value.

Overvalued

Price

$352.29

Fair value

$171.30

Current P/E

44.2

Normal P/E

21.5

Market cap

$24.79B

Dividend yield

0.3%

Return on equity

18.5%

Sector

Healthcare

Fair value compares WST's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks